Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Physiomics plc (PYC) ORD GBP0.004

Sell:6.30p Buy:6.60p 0 Change: No change
Market closed Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:6.30p
Buy:6.60p
Change: No change
Market closed Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:6.30p
Buy:6.60p
Change: No change
Market closed Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Physiomics Plc is engaged in the provision of outsourced systems and computational biology services to pharmaceutical companies. The Company is focused on the development of Virtual Tumour Clinical, to directly predict optimal regimens for human clinical trials; Cardiac tox prediction service, to predict unwanted toxic side effects of drug candidates in the drug discovery process, and Drug combinations database, for researchers and clinicians to access literature data on pre-clinical and clinical regimens and their effects. Its services include Target Validation, Mechanism of Action Studies, Lead Selection, Clinical Pharmacokinetic/Pharmacodynamics (PK/PD), EASYAP/Cardiac Toxicity Service, Virtual Tumour Preclinical and Virtual Tumour Clinical. It offers a services and technology for predicting cardiac toxicity. It also focuses on offering offer Model Based Drug Development (MBDD) services, which include Population PKPD analysis of clinical data and Back-translational analysis.

Contact details

Address:
Magdalen Centre
1 Robert Robinson Avenue
OXFORD
OX4 4GA
United Kingdom
Telephone:
+44 (01865) 784980
Website:
www.physiomics-plc.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 10 May 2021 10/05/21
Interim results 01 March 2021 01/03/21
AGM 17 November 2020 17/11/20
Annual report 22 October 2020 22/10/20
Final results 30 September 2020 30/09/20

General stock information

EPIC:
PYC
ISIN:
GB00BDR6W943
Market cap:
£6.28 million
Shares in issue:
97.33 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • James Millen
    Chief Executive Officer
  • Christophe Chassagnole
    Chief Operating Officer, Executive Director
  • Elizabeth King
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.